Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 546-551

  Horowitz, Neil S ^a,b,d   Dehdashti, Farrokh ^a,b   Herzog, Thomas J ^a,b   Rader, Janet S ^a,b   Powell, Matthew A ^a,b   Gibb, Randal K ^a,b   Grigsby, Perry W ^b,c   Siegel, Barry A ^a,b   Mutch, David G ^a,b  

^a University Schools   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

FDG PET; Lymph node metastasis; Uterine corpus cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANALYTIC METHOD; ARTICLE; BIOPSY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING SYSTEM; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

AORTA; BIOPSY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PELVIS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; UTERINE NEOPLASMS;

EID: 9944259989     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.009     Document Type: Article

References (26)

1. J. Amedin, R. Tiwari, and T. Murray Cancer statistics, 2004 CA Cancer J. Clin. 54 2004 8 29
2. R.C. Boronow, C.P. Morrow, and W.T. Creasman Surgical staging in endometrial cancer: clinical-pathologic findings in a prospective study Obstet. Gynecol. 63 1984 825 832
3. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer Cancer 60 1987 2035 2041
4. P.J. Disaia, C.P. Morrow, R. Boronow, W. Creasman, and L. Mittelstaedt Endometrial sarcoma: lymphatic spread pattern Am. J. Obstet. Gynecol. 130 1978 104 105
5. R.J. Lotocki, L.T. Copeland, A.D. DePetrillo, and W. Muirhead Stage I endometrial adenocarcinoma: treatment results in 835 patients Am. J. Obstet. Gynecol. 146 1983 141 145
6. S.C. Crawford, L. De Caestecker, and C.R. Gillis Staging quality is related to the survival of women with endometrial cancer: a Scottish population based study. Deficient surgical staging and omission of women diagnosed with endometrial cancer in Scotland during 1996 and 1997 Br. J. Cancer 86 2002 1837 1842
7. L.C. Kilgore, E.E. Partridge, and R.D. Alvarez Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling Gynecol. Oncol. 56 1995 29 33
8. P.Y. Roland, F.J. Kelly, C.Y. Kulwicki, P. Blitzer, M. Curcio, and J.W. Orr Jr. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment Gynecol. Oncol. 93 2004 125 130
9. J.P. Connor, J.I. Andrews, B. Anderson, and R.E. Buller Computed tomography in endometrial cancer Obstet. Gynecol. 95 2000 692 696
10. H. Hricak, L.V. Rubinstein, G.M. Gherman, and N. Karstaedt MR imaging evaluation of endometrial cancer: results of an NCI cooperative study Radiology 179 1991 829 832
11. O. Warburg The metabolism of tumors 1930 Arnold Constable London 75 327
12. N.K. Monakhov, E.L. Neistadt, M.M. Shavlovskii, A.L. Shvartsman, and S.A. Neifakh Physiochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissue J. Natl. Cancer Inst. 61 1978 27 34
13. M.J. Weber, E.L. Neisfadt, and D.W. Salter Molecular events leading to enhanced glucose transport in Rous sarcoma virus-transformed cells Fed. Proc. 43 1984 2246 2250
14. J.B. Bomanji, D.C. Costa, and P.J. Ell Clinical role of positron emission tomography in oncology Lancet Oncol. 2 2001 157 164
15. P.W. Grigsby, B.A. Siegel, and F. Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J. Clin. Oncol. 19 2001 3745 3759
16. P.W. Grigsby, B.A. Siegel, F. Dehdashti, and D.G. Mutch Posttherapy surveillance monitoring of cervical caner by FDG-PET Int. J. Radiat. Oncol. Biol. Phys. 55 2003 907 913
17. M.J. Reinhardt, C. Ehritt Braun, and D. Vogelgesang Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG-PET Radiology 8 2001 776 782
18. P.G. Rose, L.P. Adler, M. Rodriguez, P.F. Faulhaber, F.W. Abdul-Karim, and F. Miraldi Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgico-pathologic study J. Clin. Oncol. 17 1999 41 45
19. Y. Sugawara, A. Eisbruch, S. Kosuda, B.E. Recker, P.V. Kison, and R.L. Wahl Evaluation of FDG-PET in patients with cervical cancer J. Nucl. Med. 40 1999 1125 1131
20. 18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma Gynecol. Oncol. 51 1993 175 181
21. M. Zimny, W. Siggelkow, and W. Schröder 2-[Fluorine-18]-fluoro-2- deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer Gynecol. Oncol. 83 2001 310 315
22. D.E. Cohn, F. Dehdashti, and R.K. Gibb Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer Gynecol. Oncol. 85 2002 179 184
23. 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma Eur. J. Nucl. Med. Mol. Imaging 29 2002 1132 1139
24. T. Saga, T. Higshi, and T. Ishimori Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer Ann. Nucl. Med. 17 2003 193 203
25. H. Schöder, Y.E. Erdi, S.M. Larson, and H.W.D. Yeung PET/CT: a new imaging technology in nuclear medicine Eur. J. Nucl. Med. Mol. Imaging 30 2003 1419 1437
26. R. Wahl Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT J. Nucl. Med. 45 2004 82S 95S